Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 3/20 | 0.68 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.50 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LSS | P48449 | 2/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | S1PR2 | O95136 | 1/20 | 0.41 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.41 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.41 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.41 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28183921 | 1.00 | CYP1A2 (0.68) | CYP1A2SIGMAR1EPHX1ALDH1A1LSS | |
| SCHEMBL9206264 | 1.00 | CYP1A2 (0.68) | CYP1A2SIGMAR1EPHX1ALDH1A1LSS | |
| SCHEMBL9213811 | 1.00 | CYP1A2 (0.68) | CYP1A2SIGMAR1EPHX1ALDH1A1LSS | |
| SCHEMBL25395178 | 1.00 | CYP1A2 (0.68) | CYP1A2SIGMAR1EPHX1ALDH1A1LSS | |
| SCHEMBL9202670 | 1.00 | CYP1A2 (0.68) | CYP1A2SIGMAR1EPHX1ALDH1A1LSS | |
| SCHEMBL25395501 | 1.00 | CYP1A2 (0.68) | CYP1A2SIGMAR1EPHX1ALDH1A1LSS | |
| SCHEMBL9202673 | 1.00 | CYP1A2 (0.68) | CYP1A2SIGMAR1EPHX1ALDH1A1LSS | |
| SCHEMBL627037 | 1.00 | CYP1A2 (0.68) | CYP1A2SIGMAR1EPHX1ALDH1A1LSS | |
| SCHEMBL9118164 | 1.00 | CYP1A2 (0.68) | CYP1A2SIGMAR1EPHX1ALDH1A1LSS | |
| SCHEMBL11459435 | 1.00 | CYP1A2 (0.68) | CYP1A2SIGMAR1EPHX1ALDH1A1LSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 56 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240131040-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2024-04-25 | — | — | US | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| US-20230073802-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2023-03-09 | — | — | US | claimed |
| US-20220387376-A1 | Compositions Comprising Cannabinoid Molecules that are Dissolved in Water-Miscible Solvents | NATURAL EXTRACTION SYS LLC (US) | 2022-12-08 | — | — | US | claimed |
| US-20220387351-A1 | Compositions and Methods Related to Organic Oxides | Natural Extraction Systems, LLC | 2022-12-08 | — | — | US | claimed |
| WO-2022026960-A1 | COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS | Natural Extraction Systems, LLC (US) | 2022-02-03 | — | — | WO | claimed |
| US-20210360947-A1 | COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS | Natural Extraction Systems, LLC | 2021-11-25 | — | — | US | claimed |
| WO-2021158575-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158714-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021158573-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2021-08-12 | — | — | WO | claimed |
| WO-2021087291-A1 | COMPOSITIONS AND METHODS RELATED TO ORGANIC OXIDES | Natural Extraction Systems, LLC (US) | 2021-05-06 | — | — | WO | claimed |
| WO-2021076936-A1 | COMPOSITIONS COMPRISING CANNABINOID MOLECULES THAT ARE DISSOLVED IN WATER-MISCIBLE SOLVENTS | Natural Extraction Systems, LLC (US) | 2021-04-22 | — | — | WO | claimed |
| WO-2021041637-A1 | COMPOSITIONS COMPRISING CANNABINOID IONS DISSOLVING IN GLYCEROL | Natural Extraction Systems, LLC (US) | 2021-03-04 | — | — | WO | claimed |
| US-4178367-A | Prostaglandin I2 analogues | ONO PHARMACEUTICAL CO. LTD. (JP) | 1979-12-11 | — | — | US | claimed |
| US-12441901-B2 | Quantum dot ink composition, and quantum dot electroluminescent device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2025-10-14 | — | — | US | disclosed |
| US-20240131040-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | Natural Extraction Systems, LLC (US) | 2024-04-25 | — | — | US | disclosed |
| US-20230287231-A1 | QUANTUM DOT INK COMPOSITION, AND QUANTUM DOT ELECTROLUMINESCENT DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-09-14 | — | — | US | disclosed |
| US-4278688-A | Prostaglandin analogues | ONO PHARMACEUTICAL CO. (JP) | 1981-07-14 | — | — | US | disclosed |
| US-4234597-A | 6,9-Nitrilo(imino)-prostaglandin analogues | ONO PHARMACEUTICAL CO. LTD. (JP) | 1980-11-18 | — | — | US | disclosed |
| US-4215142-A | Prostaglandin analogues | ONO PHARMACEUTICAL CO. LTD. (JP) | 1980-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220387376-A1 | Compositions Comprising Cannabinoid Molecules that are Dissolved in Water-Miscible Solvents | CNR2, CNR1, PHOSPHO1 | CYP1A2 1223/4885SIGMAR1 227/4885EPHX1 496/4885 |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | CYP1A2 3865/4885SIGMAR1 3351/4885EPHX1 931/4885 |
| US-20220387351-A1 | Compositions and Methods Related to Organic Oxides | LPO, SLCO2A1, SLCO2B1 | CYP1A2 141/4885SIGMAR1 185/4885EPHX1 508/4885 |
| US-20240131040-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | CNR1, CNR2, OPRD1 | CYP1A2 3533/4885SIGMAR1 40/4885EPHX1 3426/4885 |
| US-20210360947-A1 | COMPOSITIONS AND METHODS RELATED TO EXCIPIENTS AND CANNABINOID FORMULATIONS | CNR2, CNR1, FAAH | CYP1A2 1794/4885SIGMAR1 2030/4885EPHX1 471/4885 |
| US-20230073802-A1 | COMPOSITIONS AND METHODS RELATED TO CANNABINOID ANIONS | CNR2, CNR1, FAAH | CYP1A2 1824/4885SIGMAR1 353/4885EPHX1 1305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.